UA98131C2 - Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи - Google Patents

Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи

Info

Publication number
UA98131C2
UA98131C2 UAA200907928A UAA200907928A UA98131C2 UA 98131 C2 UA98131 C2 UA 98131C2 UA A200907928 A UAA200907928 A UA A200907928A UA A200907928 A UAA200907928 A UA A200907928A UA 98131 C2 UA98131 C2 UA 98131C2
Authority
UA
Ukraine
Prior art keywords
azabicyclo
ylmethyl
oct
preparation
urinary incontinence
Prior art date
Application number
UAA200907928A
Other languages
English (en)
Ukrainian (uk)
Inventor
Тьєррі Клер
Жакі Тісн-Версаль
Крістоф Пшібільскі
Original Assignee
Пьєр Фабр Медікамент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пьєр Фабр Медікамент filed Critical Пьєр Фабр Медікамент
Publication of UA98131C2 publication Critical patent/UA98131C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Изобретение касается применения 10-[(3R)-1-азабицикло[2.2.2]окт-3-илметил]-10H-фенотиазина, а также его фармацевтически приемлемых солей для изготовления лекарства для профилактики или лечения недержания мочи и связанных с ним заболеваний, которые дают бактериальные или грибковые инфекции, которые развились вследствие гиперактивности пузыря с помощью селективного ингибирования М1-, М2- и М3-мускариновых рецепторов.
UAA200907928A 2006-12-28 2007-12-26 Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи UA98131C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0656002A FR2910814B1 (fr) 2006-12-28 2006-12-28 Utilisation du 10-°(r3)-1-azabicyclo°2.2.2!oct-3-ylmethyl!-10h- phenothiazine pour la preparation d'un medicament exercant une inhibition selective des recepteurs muscariniques m1,2,3
PCT/EP2007/064553 WO2008080924A1 (fr) 2006-12-28 2007-12-26 Utilisation du 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylméthyl]-10h-phénothiazine pour la préparation d'un médicament exerçant une inhibition sélective des récepteurs muscariniques m1, m2 et m3

Publications (1)

Publication Number Publication Date
UA98131C2 true UA98131C2 (ru) 2012-04-25

Family

ID=37951872

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907928A UA98131C2 (ru) 2006-12-28 2007-12-26 Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи

Country Status (22)

Country Link
US (1) US8143245B2 (ru)
EP (1) EP2124956A1 (ru)
JP (1) JP5564263B2 (ru)
KR (1) KR101465277B1 (ru)
CN (1) CN101573120B (ru)
AR (1) AR064714A1 (ru)
AU (1) AU2007341274B2 (ru)
BR (1) BRPI0720591A2 (ru)
CA (1) CA2674162A1 (ru)
FR (2) FR2910814B1 (ru)
HK (1) HK1133207A1 (ru)
IL (1) IL199557A (ru)
MA (1) MA31026B1 (ru)
MX (1) MX2009006950A (ru)
NO (1) NO20092654L (ru)
NZ (1) NZ577915A (ru)
RU (1) RU2449794C2 (ru)
TN (1) TN2009000257A1 (ru)
TW (1) TWI423806B (ru)
UA (1) UA98131C2 (ru)
WO (1) WO2008080924A1 (ru)
ZA (1) ZA200904304B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015133989A (ja) * 2015-04-28 2015-07-27 重泉 達志 健康食品
KR101969263B1 (ko) 2018-07-16 2019-04-15 이상호 산소 챔버용 산소 공급 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173445B (it) * 1984-03-16 1987-06-24 Guidotti & C Spa Labor Agenti ad attivita' antibroncospastica e composizioni farmaceutiche che li contengono
IT1251161B (it) * 1991-08-07 1995-05-04 Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono
AU6686700A (en) * 1999-08-23 2001-03-19 H. Lundbeck A/S Treatment of urinary incontinence
CA2471400A1 (en) * 2001-12-20 2003-07-03 Femmepharma, Inc. Vaginal delivery of drugs

Also Published As

Publication number Publication date
JP2010514730A (ja) 2010-05-06
AU2007341274B2 (en) 2012-09-20
CN101573120B (zh) 2011-11-23
FR2910814B1 (fr) 2011-06-17
WO2008080924A1 (fr) 2008-07-10
MA31026B1 (fr) 2009-12-01
EP2124956A1 (fr) 2009-12-02
HK1133207A1 (ru) 2010-03-19
RU2009128326A (ru) 2011-02-10
TN2009000257A1 (fr) 2010-10-18
JP5564263B2 (ja) 2014-07-30
AR064714A1 (es) 2009-04-22
US20100063276A1 (en) 2010-03-11
CN101573120A (zh) 2009-11-04
TW200833331A (en) 2008-08-16
KR101465277B1 (ko) 2014-11-27
FR2910814A1 (fr) 2008-07-04
US8143245B2 (en) 2012-03-27
MX2009006950A (es) 2009-07-14
CA2674162A1 (fr) 2008-07-10
AU2007341274A1 (en) 2008-07-10
TWI423806B (zh) 2014-01-21
FR2953721A1 (fr) 2011-06-17
NO20092654L (no) 2009-09-28
RU2449794C2 (ru) 2012-05-10
NZ577915A (en) 2011-12-22
KR20090103887A (ko) 2009-10-01
BRPI0720591A2 (pt) 2014-02-25
ZA200904304B (en) 2010-06-30
IL199557A (en) 2014-09-30

Similar Documents

Publication Publication Date Title
WO2007138472A3 (en) Triazolopyridazine derivatives
RS20080533A (en) Triazolopyrazine derivatives useful as anticancer agents
HK1095138A1 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
MX2012004848A (es) Compuestos heterociclicos triciclicos.
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
HK1095139A1 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
WO2005070930A3 (en) Tetrahydrocarboline compounds as anticancer agents
MX2010004312A (es) Derivados de 1,3,4-tiadiazol espiro-condensados para inhibir la actividad de quinesina de la proteina de quinesina del huso.
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2006065721A3 (en) 11, 12-lactone bicyclolides
WO2006031719A3 (en) 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof
TW200806321A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
TW200635600A (en) Tetracyclic bicyclolides
UA98131C2 (ru) Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
MX2010004314A (es) Compuestos para inhibir la actividad de quinesina de la proteina quinesina del huso.
WO2014047288A3 (en) Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
WO2007098090A3 (en) Treatment of hyperproliferative diseases with n-oxides of estrogen receptor modulators
UA102083C2 (ru) Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты
HK1163526A1 (en) A medicament for treating schizophrenia comprising cilostazol
TN2010000241A1 (en) Mequitazine for treating or preventing pathologies involving histamine h4 receptors
MX2010004313A (es) Compuestos para inhibir la actividad de quinesina de la proteina de quinesina del huso.
WO2008016665A3 (en) Imidazoacridine compounds for treating flt3 -mediated disorders
WO2008029300A3 (en) Methods for treating at least one condition having mt1 receptor, 5ht2b receptor, and l-type calcium channel activity